Buy Divi's Laboratories, target Rs 1170: Manas Jaiswal
Buy Divi's Laboratories Ltd. at a price target of Rs 1170 and a stoploss at Rs 1095 from entry point.

Divi's Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 4052.57 Crore to Sales Value (99.67 % of Total Sales), Scrap which contributed Rs 8.98 Crore to Sales Value (0.22 % of Total Sales), Contract Fees which contributed Rs 2.17 Crore to Sales Value (0.05 % of Total Sales) and Export Incentives which contributed Rs 2.06 Crore to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 31-03-2018, the company has reported a Standalone sales of Rs 1087.95 Crore, up 4.82 % from last quarter Sales of Rs 1037.88 Crore and up 2.33 % from last year same quarter Sales of Rs 1063.14 Crore Company has reported net profit after tax of Rs 261.60 Crore in latest quarter.
The company’s top management includes Dr.G Suresh Kumar, Dr.Murali K Divi, Dr.Ramesh B V Nimmagadda, Mr.K V K Seshavataram, Mr.Kiran S Divi, Mr.Madhusudana Rao Divi, Mr.N V Ramana, Mr.Nilima Motaparti, Mr.R Ranga Rao, Mr.S Ganapaty. Company has Price Waterhouse as its auditoRs As on 31-03-2018, the company has a total of 265,468,580 shares outstanding.
Download ET Markets APP